Karuna Therapeutics Inc (KRTX)
NASDAQ
New Drug Application (NDA) for KarXT for the treatment of schizophrenia in adults under review with a Prescription Drug User Fee Act (PDUFA) action date of September 26, 2024 Results from the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 13.08 | 4.12943962115 | 316.75 | 329.95 | 296.06 | 677629 | 318.74276093 | CS |
52 | 118.53 | 56.0955986749 | 211.3 | 329.95 | 158.375 | 515220 | 273.18851435 | CS |
156 | 220.54 | 201.793393723 | 109.29 | 329.95 | 92.26 | 358959 | 215.05019539 | CS |
260 | 310.24 | 1583.66513527 | 19.59 | 329.95 | 11.24 | 319776 | 169.34492652 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.